http://www.lilly.com
Eli Lilly and Company Company Intro
Eli Lilly and Company Homepage
Industry
Healthcare
Eli Lilly and Company Headquaters
Lilly Corporate Center
Indianapolis,46285
United States
Eli Lilly and Company Share price
22 Oct 2020 02:00 GMT
$142.29
-1.3 (-0.91 %)
Eli Lilly and Company Market cap
$135.159 B
WMC RANKING
2020
Eli Lilly and Company # 11
Drug Manufacturers—GeneralLatest Eli Lilly and Company News
22 Oct 2020
Chronic Idiopathic Constipation Drugs Market Overview with ...
... on competitive landscape provides information about key company overview, ... Pfizer, Glaxosmithkline, Roche Holding AG, Sanofi, Bayer AG, Merck, Eli Lilly, ...
22 Oct 2020
Top Brass Conference of Digital Technology Influencers on ...
Some of the event's spectacular sponsors include Eli Lilly and Company, Cummins Inc., Roche, Salesforce, Indiana Biosciences Research Institute, Phoenix ...
22 Oct 2020
Global Cancer Cachexia Market Key Vendors, Current Trends by Manufacturers, Countries and Forecast to 2026| Aeterna Zentaris, Alder BioPharmaceuticals, Aphios, Eli Lilly, GTx
Aeterna Zentaris, Alder BioPharmaceuticals, Aphios, Eli Lilly, GTx, Helsinn, ... recent developments and trends, drivers and restrain factors, company profile, ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Eli Lilly and Company | 28.38 | 31.95 | 15.44 | 0 | 0 | 0 | 20.52 |
| Johnson & Johnson | 100 | 100 | 32.98 | 100 | 0 | 0 | 100 |
| Merck & Co., Inc. | 58.37 | 20.68 | 42.11 | 0 | 0 | 0 | 26.96 |
| AbbVie Inc. | 42.12 | 7.16 | 100 | 0 | 0 | 0 | 46.03 |
| AstraZeneca PLC | 31.78 | 23.63 | 12.28 | 2 | 0 | 0 | 16.11 |
Eli Lilly and Company Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Eli Lilly and Company | $22,949,800 | $12,225,000 | $5,618,100 | $135.159B | 11 |
| Johnson & Johnson | $80,856,000 | $33,169,000 | $16,986,000 | $378.942B | 1 |
| Merck & Co., Inc. | $47,194,000 | $20,494,000 | $10,479,000 | $197.458B | 2 |
| AbbVie Inc. | $34,057,000 | $12,564,000 | $8,394,000 | $146.287B | 3 |
| AstraZeneca PLC | $25,699,000 | $17,950,000 | $2,148,000 | $103.934B | 4 |